Hamlin Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182M Sell
714,820
-21,671
-3% -$5.05M 4.08% 10
2026
Q1
$180M Sell
736,491
-99,607
-12% -$23.2M 4.35% 10
2025
Q4
$173M Sell
836,098
-29,772
-3% -$5.89M 4.15% 9
2025
Q3
$161M Sell
865,870
-5,060
-0.6% -$867K 3.65% 17
2025
Q2
$133M Sell
870,930
-250,259
-22% -$38.5M 3.08% 21
2025
Q1
$186M Buy
1,121,189
+44,449
+4% +$6.95M 4.45% 7
2024
Q4
$156M Buy
1,076,740
+94,147
+10% +$14.6M 3.86% 15
2024
Q3
$159M Buy
982,593
+130,305
+15% +$20.8M 4% 13
2024
Q2
$125M Sell
852,288
-207
-0% -$30.8K 3.67% 17
2024
Q1
$135M Buy
852,495
+56,749
+7% +$9.03M 3.98% 13
2023
Q4
$125M Buy
795,746
+55,259
+7% +$8.47M 3.93% 13
2023
Q3
$115M Buy
740,487
+3,297
+0.4% +$544K 3.97% 12
2023
Q2
$122M Sell
737,190
-2,122
-0.3% -$342K 4.09% 12
2023
Q1
$115M Buy
739,312
+28,590
+4% +$4.62M 4% 14
2022
Q4
$126M Buy
710,722
+14,598
+2% +$2.52M 4.46% 7
2022
Q3
$114M Buy
696,124
+6,946
+1% +$1.18M 4.54% 6
2022
Q2
$122M Buy
689,178
+7,969
+1% +$1.42M 4.9% 3
2022
Q1
$121M Buy
681,209
+162,556
+31% +$27.7M 4.26% 7
2021
Q4
$88.7M Buy
518,653
+17,489
+3% +$2.86M 3.15% 25
2021
Q3
$80.9M Sell
501,164
-2,413
-0.5% -$412K 3.22% 21
2021
Q2
$83M Buy
503,577
+40,378
+9% +$6.68M 3.27% 20
2021
Q1
$76.1M Buy
463,199
+2,272
+0.5% +$368K 3.12% 22
2020
Q4
$72.5M Sell
460,927
-4,361
-0.9% -$644K 3.35% 18
2020
Q3
$69.3M Sell
465,288
-15,287
-3% -$2.26M 3.66% 15
2020
Q2
$67.6M Buy
480,575
+30,801
+7% +$4.49M 3.61% 4
2020
Q1
$59M Buy
449,774
+168,996
+60% +$24M 3.53% 8
2019
Q4
$41M Buy
+280,778
New +$38.1M 1.7% 30
2019
Q1
Sell
-2,082
Closed -$269K 41
2018
Q4
$269K Sell
2,082
-136
-6% -$19K 0.01% 47
2018
Q3
$306K Hold
2,218
0.01% 40
2018
Q2
$269K Hold
2,218
0.01% 38
2018
Q1
$284K Buy
+2,218
New +$300K 0.01% 41

Other funds holding JNJ

Hamlin Capital Management's JNJ Position: Q2 2026 in Review

Hamlin Capital Management reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, selling an estimated $5.05M and leaving 714,820 shares worth $182M. The position accounts for 4.08% of the portfolio, ranked #10.

Hamlin Capital Management first reported a position in JNJ in Q1 2018 and has held it in 31 quarters since. The position peaked at $186M in Q1 2025. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hamlin Capital Management held 714,820 shares of Johnson & Johnson worth $182M as of Q2 2026.
  • Hamlin Capital Management sold 21,671 Johnson & Johnson shares in Q2 2026, an estimated $5.05M.
  • Johnson & Johnson made up 4.08% of Hamlin Capital Management's portfolio in Q2 2026, its #10 holding.
  • Hamlin Capital Management first reported a position in Johnson & Johnson in Q1 2018 and has held it in 31 quarters since.
  • Hamlin Capital Management's Johnson & Johnson position peaked at $186M in Q1 2025.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hamlin Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.